AdraCard

AdraCard develops a proprietary drug delivery solution aimed at preventing hospitalizations and deaths from anaphylaxis by integrating adrenaline administration into everyday life. The company's mission is to address limitations of current adrenaline delivery methods, such as bulkiness, short shelf life, susceptibility to temperature, needle phobia, and low compliance. AdraCard's approach centers on accessibility, ease of use, and safety, underpinned by a team with extensive experience in drug-device development.